HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment. Read more about HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma. Read more about Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer. Read more about Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.
BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas. Read more about BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Read more about Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy. Read more about Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
HER2 and HER3 in HPV+ and HPV- HNSCC--Response. Read more about HER2 and HER3 in HPV+ and HPV- HNSCC--Response.
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Read more about Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
Quantitative Imaging in Cancer Clinical Trials. Read more about Quantitative Imaging in Cancer Clinical Trials.
Neoadjuvant as Future for Drug Development in Breast Cancer--Response. Read more about Neoadjuvant as Future for Drug Development in Breast Cancer--Response.
